Home ›
Organizations ›
NEW ENGLAND BAPTIST HOSPITAL
NEW ENGLAND BAPTIST HOSPITAL
MA · Healthcare · EIN 042103612
63
Executives Disclosed
$219.3M
Annual Revenue
$275.5M
Total Assets
16.4:1
Internal Pay Ratio
NEW ENGLAND BAPTIST HOSPITAL has 63 executives with disclosed compensation. The highest-paid executive, Kevin Tabb, MD (CEO (EX-OFF) (CEO, BILH)), received peak total compensation of $5,410,415. The sector average for Healthcare executives is $506K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Kevin Tabb, MD | CEO (EX-OFF) (CEO, BILH) | $5.4M | $5.4M | 2019–2024 | 72.1x |
| Michael Rowan | TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH | $4.7M | $4.7M | 2022–2024 | 62.7x |
| Patricia Hannon, FACHE | FORMER PRESIDENT, CEO & TRUSTEE | $3.8M | $223K | 2016–2022 | 50.2x |
| Steven P Fischer | FORMER TREASURER (EX-OFFICIO) | $1.7M | $1.0M | 2019–2022 | 23.2x |
| Cindy Rios | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | $1.7M | $1.7M | 2023–2024 | 22.5x |
| Peter Healy | TTEE (EXO) (DIV PRES, METRO BOSTON) | $1.7M | $1.7M | 2024–2024 | 22.4x |
| David Mattingly, MD | TTEE; SURG. CHIEF & ORTHO CHAIR | $1.6M | $1.6M | 2016–2024 | 21.8x |
| Daniel Ward, MD | CHIEF, DIVISION OF ARTHROPLASTY | $1.5M | $1.5M | 2024–2024 | 20.2x |
| John Kerndl | TREAS (EX-OFF) (EVP & CFO, BILH) | $1.4M | $1.3M | 2022–2023 | 18.6x |
| Stanley M Lewis, MD | TRUSTEE (CEO DESIGNATE) | $1.4M | $1.4M | 2019–2020 | 18.1x |
| Jamie Katz, ESQ | CLERK (EX-OFF); GENERAL COUNSEL BILH | $1.3M | $1.3M | 2019–2024 | 17.4x |
| Eric Smith, MD | TTEE (EXO) (CHAIR ORTHO; SURG CHIEF) | $1.1M | $1.1M | 2023–2024 | 14.7x |
| David Passafaro | PRESIDENT & TRUSTEE (EX-OFFICIO) | $834K | $834K | 2017–2024 | 11.1x |
| Linda E Thompson | FRMR, SVP HR & SERVICE EXCELLENCE | $832K | $110K | 2016–2024 | 11.1x |
| Passafaro David Anthony | TRUSTEE (EX-OFF), PRESIDENT | $731K | $731K | 2020–2020 | 9.7x |
| Samir Patel, MD | ANESTHESIOLOGIST | $697K | $697K | 2024–2024 | 9.3x |
| Facc Frederick Basilico, MD | TTEE (EXOFF); CHIEF PHYS & MED CHAIR | $638K | $638K | 2024–2024 | 8.5x |
| Msf Thomas J Gheringhelli | FRMR ASST TREAS, SVP FINANCE & CFO | $622K | $292K | 2016–2024 | 8.3x |
| Mary Sullivan Smith, RN, MS | TTEE (EX-OFF); SENIOR VP, COO & CNO | $600K | $536K | 2017–2024 | 8x |
| Sullivan Smith Mary | SVP, COO & CNO | $556K | $556K | 2022–2022 | 7.4x |
| Brian Hollenbeck, MD | TTEE (EX-OFF),SRVP,CMO CHF,INFCT DIS | $545K | $545K | 2022–2024 | 7.3x |
| Jayne Sheehan, RN, MSN | FRMR VP MUSC. NET. DEV., NEBH & BILH | $533K | $232K | 2020–2024 | 7.1x |
| Roberto Cruz-Gervis, MD | TTEE (EX-OFF) (PRES, NEBH MED STAFF) | $505K | $505K | 2022–2024 | 6.7x |
| Elizabeth Greenspan | FMR SVP, CHIEF STRATEGY OFF | $499K | $142K | 2016–2019 | 6.6x |
| Maureen Mulkerrin, MS, RN | FORMER VP, TECHNOLOGY & CIO | $445K | $457K | 2016–2017 | 5.9x |
| Jihad Hayek, MD | CHAIR OF PATHOLOGY | $439K | $439K | 2016–2023 | 5.9x |
| Jihad Jay Hayek, MD | CHIEF, DEPARTMENT OF PATHOLOGY | $428K | $428K | 2024–2024 | 5.7x |
| Sullivan Smith Rnmsmary | TTEE(EX-OFF)/COO/CNO/CHF COMPL | $388K | $403K | 2016–2016 | 5.2x |
| Facc Frederick C Basilico, MD | TTEE (EXOFF); CHIEF PHYS & MED CHAIR | $359K | $356K | 2016–2023 | 4.8x |
| Scott W Anderson | AVP, PATIENT FIN. SERV. | $338K | $338K | 2019–2019 | 4.5x |
| Brian Smith, MBA | ASST TREAS; METRO BOSTON & NEBH CFO | $335K | $335K | 2023–2024 | 4.5x |
| Herman Katherine Morgan | VICE PRESIDENT OF PHILANTHROPY | $330K | $330K | 2018–2019 | 4.4x |
| Patricia Ide | EXEC. DIR., QUALITY & PATIENT SVCS | $329K | $269K | 2020–2023 | 4.4x |
| Gary Schneider | CHIEF OF RESEARCH | $323K | $332K | 2016–2017 | 4.3x |
| Edward Reardon | VICE PRESIDENT, PHILANTHROPY | $311K | $311K | 2024–2024 | 4.1x |
| Morgan Herman | VP OF PHILANTHROPY | $310K | $310K | 2016–2016 | 4.1x |
| Herman K Morgan | VP OF PHILANTHROPY | $307K | $307K | 2017–2017 | 4.1x |
| Stephen Boyd, ESQ | FRMR ASST CLRK(EXOFF),AVP,AST DEP GC | $306K | $306K | 2022–2023 | 4.1x |
| Scott Tromanhauser, MD | TEE/CHF MED QTY OFF/RES OP DIR | $298K | $555K | 2016–2020 | 4x |
| Gail Sebet | SENIOR DIR SURGICAL SERVICES | $293K | $293K | 2020–2020 | 3.9x |
| Leo Buckley | EXEC DIRECTOR, SURGICAL BUSINESS OPS | $284K | $284K | 2024–2024 | 3.8x |
| Barbara E McKinnon | NURSE MANAGER | $282K | $282K | 2019–2019 | 3.8x |
| Timothy S Coutu | MANAGER OF FINANCIAL AND ADMIN APPS | $275K | $237K | 2020–2022 | 3.7x |
| Rachel Rosenblum, MHA | VP, CLIN PROG DESIGN & BUS DEV | $272K | $283K | 2016–2016 | 3.6x |
| Ann E Callahan | OR NURSE | $267K | $206K | 2016–2022 | 3.6x |
| Valerie J Giordano | CHIEF OF STAFF & VP, REAL ESTATE | $266K | $266K | 2022–2022 | 3.6x |
| Daniel E Lefaivre | EXECUTIVE DIRECTOR, FINANCE | $257K | $257K | 2020–2020 | 3.4x |
| Leo F Buckley | EXEC DIR SURG BUS OPS PT ACCESS | $255K | $255K | 2023–2023 | 3.4x |
| Lauren Finnegan | EXEC DIR NEBMA & MED STAFF | $252K | $252K | 2019–2019 | 3.4x |
| Campbell Beaudet Jayne | OR NURSE | $245K | $245K | 2018–2018 | 3.3x |
| Valerie Giordano | CHIEF OF STAFF, VICE PRESIDENT | $241K | $241K | 2020–2020 | 3.2x |
| Val Giordano, RN | CHIEF STAFF & VP, STRAT. PLAN/RE | $240K | $240K | 2023–2024 | 3.2x |
| Sharyn Z Heinzelman | EXEC DIR PERIOPERATIVE SERVICES | $238K | $238K | 2023–2023 | 3.2x |
| Daniel Lefaivre | FRMR ASST TREAS (EX-OFF) & CFO | $231K | $195K | 2022–2024 | 3.1x |
| April Timko, ESQ | ASST CLERK (ASSOC GC BILH) | $216K | $216K | 2023–2024 | 2.9x |
| Paige Legassie | VP, HUMAN RESOURCES BUSINESS PARTNER | $214K | $214K | 2023–2024 | 2.9x |
| Kathryn Gevitz, ESQ | FRMR ASST CLERK (EXOFF)/ASST GC,BILH | $199K | $199K | 2022–2023 | 2.7x |
| Frederick C Basilico, MD | TEE (EX-OFF)/CHAIR OF MED/SEC | $179K | $329K | 2020–2020 | 2.4x |
| Damon J Spitz, MD | TRUSTEE (EX-OFF), PRES MED STAFF, CHAIR RADIO DEPT | $111K | $0 | 2017–2022 | 1.5x |
| John C Richmond, MD | MED. DIR. OF NTWRK DEVEL | $110K | $219K | 2016–2018 | 1.5x |
| Mary Battista | ASSISTANT CLERK | $85K | $0 | 2020–2020 | 1.1x |
| John Jackson | TRUSTEE | $54K | $0 | 2023–2023 | 0.7x |
| Robert Bode, MD | BRD CHR/TTEE (EX-OFF)/ANES CHR | $37K | $0 | 2016–2017 | 0.5x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 16 | $380K | $1.2M | $5.7M |
| 2017 | 17 | $403K | $1.2M | $6.0M |
| 2018 | 15 | $429K | $1.3M | $6.0M |
| 2019 | 19 | $719K | $4.0M | $12.9M |
| 2020 | 20 | $760K | $3.3M | $13.7M |
| 2022 | 23 | $812K | $5.3M | $17.9M |
| 2023 | 26 | $628K | $2.8M | $15.7M |
| 2024 | 25 | $1.0M | $5.4M | $25.6M |